Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A precisely humanized FCRN transgenic mouse for preclinical pharmacokinetics studies

2 Mar 2023

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to CRISPR and Genetic Engineering
Share to Monoclonal and Polyclonal Antibodies Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 36870576
DOI: 10.1016/j.bcp.2023.115470

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A precisely humanized FCRN transgenic mouse for preclinical pharmacokinetics studiesPMID 36870576Read ↗

Humanized FcRn mouse models for evaluating pharmacokinetics of human IgG antibodiesSemantic proximity Read ↗

Human FcRn transgenic mice for pharmacokinetic evaluation of therapeutic antibodies.Semantic proximity Read ↗

A HUMANIZED FCRN TRANSGENIC MOUSE FOR PRECLINICAL PHARMACOKINETICS STUDIESSemantic proximity Read ↗

Clinical chemistry of human FcRn transgenic miceSemantic proximity Read ↗

Utility of a human FcRn transgenic mouse model in drug discovery for early assessment and prediction of human pharmacokinetics of monoclonal antibodiesSemantic proximity Read ↗

Transgenic Mouse Strains as Platforms for the Successful Discovery and Development of Human Therapeutic Monoclonal AntibodiesSemantic proximity Read ↗

Functional humanization of immunoglobulin heavy constant gamma 1 Fc domain human FCGRT transgenic miceSemantic proximity Read ↗

Discovery and bio‐optimization of human antibody therapeutics using the XenoMouse® transgenic mouse platformSemantic proximity Read ↗

Antibody discovery: the use of transgenic mice to generate human monoclonal antibodies for therapeuticsSemantic proximity Read ↗

From XenoMouse technology to panitumumab, the first fully human antibody product from transgenic miceSemantic proximity Read ↗

High-avidity human IgGκ monoclonal antibodies from a novel strain of minilocus transgenic miceSemantic proximity Read ↗

Quantitative Prediction of Human Pharmacokinetics for Fc-Engineered Therapeutic Monoclonal Antibodies With Increased FcRn Binding Mutations After Subcutaneous Injection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.